Karyopharm Therapeutics I... (KPTI)
0.67
-0.03 (-4.05%)
At close: Jan 17, 2025, 3:59 PM
0.66
-0.74%
After-hours Jan 17, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -143.10M | -165.29M | -124.09M | -196.27M | -199.59M | -178.41M | -128.98M | -109.58M | -118.18M | -75.78M | -33.95M | -15.89M | -10.31M |
| Depreciation & Amortization | 530.00K | 621.00K | 789.00K | 972.00K | 974.00K | 735.00K | 713.00K | 717.00K | 634.00K | 323.00K | 144.00K | 122.00K | 83.00K |
| Stock-Based Compensation | 21.71M | 35.40M | 29.78M | 24.41M | 15.29M | 17.27M | 20.41M | 22.28M | 17.06M | 14.24M | 3.79M | 653.00K | 24.00K |
| Other Working Capital | 9.76M | -15.96M | -9.26M | 5.54M | -1.80M | 1.21M | 32.05M | 42.00K | 6.42M | 5.22M | -1.02M | -330.00K | 524.00K |
| Other Non-Cash Items | -3.28M | -294.00K | 8.13M | 8.40M | 7.19M | 1.42M | 1.19M | 1.20M | 685.00K | 52.00K | 88.00K | 257.00K | n/a |
| Deferred Income Tax | n/a | n/a | 1.45M | 904.00K | -1.38M | 29.00K | n/a | n/a | 1.78M | n/a | n/a | n/a | n/a |
| Change in Working Capital | 31.41M | -19.99M | -23.19M | 1.36M | -13.31M | -169.00K | 32.96M | 987.00K | 4.00M | 9.71M | -360.00K | -396.00K | 1.66M |
| Operating Cash Flow | -92.72M | -149.55M | -107.12M | -160.23M | -190.82M | -159.12M | -73.72M | -84.39M | -94.03M | -51.45M | -30.29M | -15.51M | -8.55M |
| Capital Expenditures | n/a | -118.00K | -5.71M | -145.00K | -206.00K | -2.36M | -62.00K | -70.00K | -1.42M | -2.83M | -57.00K | -121.00K | -376.00K |
| Acquisitions | n/a | 104.26M | 5.50M | 53.54M | -78.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -159.15M | -226.02M | -45.23M | -274.58M | -178.49M | -242.81M | -98.37M | -134.70M | -305.19M | -63.80M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 167.09M | 121.88M | 192.78M | 221.04M | 257.14M | 137.51M | 115.54M | 159.37M | 215.87M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -104.26M | -5.50M | -53.54M | 78.66M | -105.30M | 17.17M | 24.66M | -82.00K | -400.00K | n/a | n/a | n/a |
| Investing Cash Flow | 7.94M | -104.26M | 141.84M | -53.69M | 78.45M | -107.66M | 17.11M | 24.59M | -90.82M | -67.03M | -57.00K | -121.00K | -376.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | 166.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.12M | 3.98M | 63.74M | 10.31M | 78.11M | 3.52M | 858.00K | 591.00K | 616.00K | 284.00K | 72.78M | 9.50M | 11.98M |
| Financial Cash Flow | 1.12M | 193.74M | 73.65M | 172.08M | 124.31M | 316.11M | 75.74M | 51.16M | 92.70M | 113.12M | 185.93M | 9.51M | 11.99M |
| Net Cash Flow | -83.69M | -60.56M | 108.32M | -41.57M | 11.95M | 49.25M | 19.33M | -8.70M | -92.25M | -5.37M | 155.58M | -6.12M | 3.07M |
| Free Cash Flow | -92.72M | -149.67M | -112.83M | -160.38M | -191.03M | -161.48M | -73.78M | -84.46M | -95.44M | -54.28M | -30.35M | -15.63M | -8.93M |